| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |